mRNA Bird Flu Vaccine Enters Final Trial in US and UK
Scientists are testing an mRNA vaccine that could be ready before a bird flu pandemic ever starts. Unlike COVID-19, this time we'd have protection waiting on the shelf.
Search
Find uplifting stories about heroes, innovations, and solutions
18 results for "mrna vaccine"
mRNA Cancer Vaccines Show Promise After Difficult Year
After political backlash threatened to derail cancer research, mRNA vaccines are delivering real hope to patients with deadly diseases like pancreatic cancer. New funding and positive trial results suggest the technology could save thousands of lives.
Pancreatic Cancer Vaccine: Patients Survive 6+ Years
A personalized mRNA vaccine is helping pancreatic cancer patients survive six years and counting, with nearly 90% of responders still alive. For a disease with just 13% five-year survival, this breakthrough offers real hope.
Pancreatic Cancer Vaccine Keeps 7 Patients Alive After 6 Years
A personalized mRNA vaccine helped eight pancreatic cancer patients generate powerful immune responses, and seven of them are still alive six years later. The breakthrough offers new hope for one of the deadliest cancers, where fewer than 13% of patients survive five years.
Man With No Medical Training Saves Dog With AI-Made Vaccine
An Australian pet owner with zero scientific background used ChatGPT to design a personalized cancer treatment that saved his dog's life. OpenAI's CEO calls it both inspiring and a wake-up call about AI's growing power.
mRNA Vaccines: Proven Success Story Continues to Grow
mRNA vaccines prevented eight million COVID infections in their first six months and now show promise for treating cancer. Despite recent political setbacks, scientists remain confident this breakthrough technology will transform medicine.
Journalist Shows Why Scientific Breakthroughs Face Pushback
Science journalist Matt Kaplan reveals how game-changing discoveries from DNA to mRNA vaccines initially faced fierce resistance, even from experts. His new book celebrates the persistence of scientists who proved the doubters wrong.
Moderna Pays $950M to Settle mRNA Vaccine Patent Dispute
Moderna has agreed to pay Roivant up to $2.25 billion to settle a patent lawsuit over its groundbreaking Covid-19 vaccine technology. The settlement could become one of the largest in patent history while keeping life-saving vaccine innovation moving forward.
🚀
Yale Scientist's RNA Discovery Still Powers Today's Vaccines
A 1989 Nobel Prize-winning discovery revealed RNA could perform chemistry, not just carry instructions. That breakthrough now enables mRNA vaccines, CRISPR gene editing, and treatments for diseases once thought incurable.
FDA Approves Review of First mRNA Flu Vaccine
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
Cancer Vaccine Keeps 11 Breast Cancer Patients Disease-Free
A personalized mRNA vaccine helped 11 women with aggressive breast cancer stay cancer-free for up to six years. The groundbreaking treatment trained their immune systems to recognize and fight cancer cells using their own tumor's genetic code.
FDA Will Review Moderna's mRNA Flu Vaccine After All
After rejecting Moderna's flu vaccine application just a week ago, the FDA reversed course and will now review the promising mRNA shot. The new technology could revolutionize how we protect ourselves from seasonal flu.
COVID Vaccine During Pregnancy Safe for Child Development
A major new study of 434 children brings reassuring news for pregnant mothers: getting the COVID-19 mRNA vaccine during pregnancy shows no link to autism or developmental delays. The research tracked children up to 30 months old and found identical outcomes whether mothers received the vaccine or not.
UK Approves First Homegrown mRNA Vaccine at New Facility
Britain just approved its first domestically manufactured mRNA vaccine, marking a major milestone in pandemic preparedness. The new Moderna facility in Oxfordshire can produce up to 250 million doses per year during health emergencies.
🧘
Mexico to Produce mRNA Vaccines with Moderna Deal
Mexico signed a groundbreaking agreement with Moderna to manufacture mRNA vaccines domestically, including potential vaccines for dengue and cancer. The five-year partnership will transfer cutting-edge vaccine technology to Mexican facilities and support local scientific research.
New mRNA Malaria Vaccine Beats Parasite's Defense System
Scientists have cracked a major puzzle in malaria prevention using mRNA vaccine technology to overcome a natural barrier that weakened previous vaccines. The breakthrough could transform protection against a disease that still causes hundreds of millions of infections each year.
Cancer Vaccine Cuts Melanoma Return Risk by Half After 5 Years
A personalized mRNA cancer vaccine combined with immunotherapy reduced the risk of deadly skin cancer returning by nearly 50% over five years. The breakthrough treatment is now entering final-stage trials while researchers test similar vaccines for lung, bladder, and kidney cancers.
Melanoma Vaccine Cuts Cancer Return Risk by 49% in Trial
A personalized mRNA vaccine from Moderna and Merck has shown remarkable five-year results against aggressive skin cancer. The therapy nearly halves the risk of melanoma returning after surgery.